Navigation Links
Onyx Pharmaceuticals to Present at Upcoming Investor Conferences
Date:2/21/2012

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2012 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at four investor conferences in February and March.

2012 Citi Global Healthcare Conference
Onyx will present at the 2012 Citi Global Healthcare Conference on Monday, February 27, 2012 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time). 

Cowen and Company 32nd Annual Health Care Conference
Onyx will present at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012 at 9:20 a.m. Eastern Time (6:20 a.m. Pacific Time). 

24th Annual ROTH Conference
Onyx will present at the 24th Annual ROTH Conference on Monday, March 12, 2012 at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time). 

Barclays Capital Global Healthcare Conference
Onyx will present at the Barclays Capital Global Healthcare Conference on Tuesday, March 13, 2012 at 9:30 a.m. Eastern Time (6:30 a.m. Pacific Time). 

Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx.com/investors/event-calendar

It is recommended that listeners log on 15 minutes early in order to register and download any necessary software.  For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through the following dates:

  • 2012 Citi Global Healthcare Conference - March 12, 2012
  • Cowen and Company 32nd Annual Health Care Conference - March 21, 2012
  • 24th Annual ROTH Conference – March 26, 2012
  • Barclays Capital Global Healthcare Conference – March 27, 2012

 

About Onyx Pharmaceuticals, Inc.
Based in South San Francisco, California, Onyx Pharmaceuticals, Inc. is a global biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.  The company is focused on developing novel medicines that target key molecular pathways. For more information about Onyx, visit the company's website at www.onyx.com.


'/>"/>
SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
2. Swedish Bactiguard to Enter Into an Exclusive Distribution Agreement With Cadila Pharmaceuticals
3. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
4. Questcor Pharmaceuticals to Present at the Leerink Swann Global Healthcare Conference on February 16, 2012
5. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
6. MAP Pharmaceuticals Appoints W. James OShea to Board of Directors
7. Inovio Pharmaceuticals to Present at Noble Financial 8th Annual Equity Conference
8. Reata Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
9. Keryx Biopharmaceuticals to Present at JP Morgans 30th Annual Healthcare Conference
10. Inovio Pharmaceuticals Promotes Niranjan Sardesai to Chief Operating Officer
11. Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... From wearable devices that can ... sports. On Thursday, December 15th a panel of entrepreneurs, innovators and a Philadelphia ... at a Smart Talk session. Smart Talk will run from 8:30 – 10:30 ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... to control cells — optogenetics — is key to exciting advances in the ... art, spatially patterned light projected via free-space optics stimulates small, transparent organisms and ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc announced today ... demand KbioBox developed a sophisticated “3 click” gene dditing off target analysis program ... new website, https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. ...
(Date:12/8/2016)... 8, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... developing and commercializing products to treat rare diseases where ... it will be hosting an Investor Webcast Event Friday, ... origins of innate defense regulators (IDRs) as a new ... mucositis and the recently announced and published Phase 2 ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
Breaking Biology News(10 mins):